Pediatric hodgkin lymphoma, version 3.2021

Jamie E. Flerlage, Susan M. Hiniker, Saro Armenian, Ellen C. Benya, Adam J. Bobbey, Vivian Chang, Stacy Cooper, Don W. Coulter, Branko Cuglievan, Bradford S. Hoppe, Leidy Isenalumhe, Kara Kelly, Leslie Kersun, Adam J. Lamble, Nicole A. Larrier, Jeffrey Magee, Kwadwo Oduro, Martha Pacheco, Anita P. Price, Kenneth B. RobertsChristine M. Smith, Aliyah R. Sohani, Erin M. Trovillion, Emily Walling, Ana C. Xavier, Jennifer L. Burns, Mallory Campbell

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for pediatric HL provide recommendations on the workup, diagnostic evaluation, and treatment of classic HL, including principles of pathology, imaging, staging, systemic therapy, and radiation therapy. This portion of the NCCN Guidelines focuses on the management of pediatric classic HL in the upfront and relapsed/refractory settings.

Original languageEnglish (US)
Pages (from-to)733-754
Number of pages22
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume19
Issue number6
DOIs
StatePublished - Jun 2021

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Pediatric hodgkin lymphoma, version 3.2021'. Together they form a unique fingerprint.

Cite this